| PRP | 1) Progressive Rubella Panencephalitis 2) Platelet Rich Plasma &... |
|---|---|
| TORCH | TOxoplasma, Rubella, Cytomegalovirus, Herpes, syphilis |
| CR | calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio... |
| CRD | carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint... |
| CRI | Cardiac Risk Index; catheter-related infection; chronic renal insufficiency; chronic respiratory ins... |
| rubella vaccine | A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunised and do not have serum antibodies to rubella. Children are usually immunised with measles-mumps-rubella combination vaccine. (12 Dec 1998) |
|---|---|
| rubella virus | The type (and only) species of rubivirus causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis. (12 Dec 1998) |
| rubella virus vaccine | A live virus vaccine prepared from duck embryo or human diploid cell culture infected with rubella virus; administered as a single subcutaneous injection. See: measles, mumps, and rubella vaccine. (05 Mar 2000) |
| congenital rubella syndrome | <syndrome> Foetal infection with rubella virus during the first trimester of pregnancy resulting in a series of congenital abnormalities including heart disease, deafness, and blindness. (05 Mar 2000) |
| immunization, rubella | See Immunization, MMR. (12 Dec 1998) |